Business Description
Biomark Diagnostics Inc
NAICS : 541380
SIC : 8681
ISIN : CA09073K1084
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | -0.42 | |||||
Debt-to-Equity | -1.94 | |||||
Debt-to-EBITDA | -1.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.13 | |||||
Beneish M-Score | -3.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 2 | |||||
3-Year FCF Growth Rate | -22.4 | |||||
3-Year Book Growth Rate | -32.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.19 | |||||
9-Day RSI | 45.53 | |||||
14-Day RSI | 44.61 | |||||
6-1 Month Momentum % | -12 | |||||
12-1 Month Momentum % | -31.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.28 | |||||
Cash Ratio | 0.23 | |||||
Days Sales Outstanding | 69.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 0.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -999.39 | |||||
Net Margin % | -937.81 | |||||
FCF Margin % | -575 | |||||
ROA % | -177.97 | |||||
ROIC % | -139.8 | |||||
ROC (Joel Greenblatt) % | -232.09 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 235 | |||||
EV-to-EBIT | -15.31 | |||||
EV-to-EBITDA | -21.1 | |||||
EV-to-Revenue | 134.93 | |||||
EV-to-FCF | -23.47 | |||||
Earnings Yield (Greenblatt) % | -6.53 | |||||
FCF Yield % | -4.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biomark Diagnostics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.164 | ||
EPS (TTM) (C$) | -0.06 | ||
Beta | -1.37 | ||
Volatility % | 47.51 | ||
14-Day RSI | 44.61 | ||
14-Day ATR (C$) | 0.007109 | ||
20-Day SMA (C$) | 0.235 | ||
12-1 Month Momentum % | -31.25 | ||
52-Week Range (C$) | 0.17 - 0.33 | ||
Shares Outstanding (Mil) | 90.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biomark Diagnostics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biomark Diagnostics Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Biomark Diagnostics Inc Frequently Asked Questions
What is Biomark Diagnostics Inc(XCNQ:BUX)'s stock price today?
When is next earnings date of Biomark Diagnostics Inc(XCNQ:BUX)?
Does Biomark Diagnostics Inc(XCNQ:BUX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |